Carbamazepine-Induced Liver Injury Requires CYP3A-Mediated Metabolism and Glutathione Depletion in Rats

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Drug Metabolism And Disposition

• Publication date

  2015-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/dmd.115.063370PMID 25870103
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Th2 cytokine‐mediated methimazole‐induced acute liver injury in mice

  2012cited by this paper
• Metabolic activation and inflammation reactions involved in carbamazepine-induced liver injury.

  2012influential reference
• Species Differences in Tissue Distribution and Enzyme Activities of Arylacetamide Deacetylase in Human, Rat, and Mouse

  2012cited by this paper
• Ticlopidine-induced hepatotoxicity in a GSH-depleted rat model

  2011cited by this paper
• Pharmacokinetic interaction studies of tanshinones with tolbutamide, a model CYP2C11 probe substrate, using liver microsomes, primary hepatocytes and in vivo in the rat.

  2010cited by this paper
• Mechanism-based biomarker gene sets for glutathione depletion-related hepatotoxicity in rats.

  2010cited by this paper
• Hepatotoxic interaction of sulindac with lipopolysaccharide: role of the hemostatic system.

  2009cited by this paper
• Metabolism-dependent hepatotoxicity of amodiaquine in glutathione-depleted mice

  2009cited by this paper
• The crucial protective role of glutathione against tienilic acid hepatotoxicity in rats.

  2008influential reference
• Role of biotransformation in 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats.

  2008cited by this paper
• Hepatotoxicity associated with antiepileptic drugs

  2008cited by this paper
• Pathways of Carbamazepine Bioactivation in Vitro. III. The Role of Human Cytochrome P450 Enzymes in the Formation of 2,3-Dihydroxycarbamazepine

  2008cited by this paper
• Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract.

  2007cited by this paper
• Idiosyncratic Adverse Reactions to Antiepileptic Drugs

  2007cited by this paper
• Idiosyncratic drug reactions: current understanding.

  2007cited by this paper
• Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha.

  2007cited by this paper
• Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine

  2006influential reference
• Antiepileptic drugs and liver disease.

  2006cited by this paper
• HUMAN IN VITRO GLUTATHIONYL AND PROTEIN ADDUCTS OF CARBAMAZEPINE-10,11-EPOXIDE, A STABLE AND PHARMACOLOGICALLY ACTIVE METABOLITE OF CARBAMAZEPINE

  2005cited by this paper
• Comparative metabonomics of differential hydrazine toxicity in the rat and mouse.

  2005cited by this paper
• PATHWAYS OF CARBAMAZEPINE BIOACTIVATION IN VITRO: II. THE ROLE OF HUMAN CYTOCHROME P450 ENZYMES IN THE FORMATION OF 2-HYDROXYIMINOSTILBENE

  2005cited by this paper
• Outcome and prognostic markers in severe drug‐induced liver disease

  2005cited by this paper
• The role of metabolic activation in drug-induced hepatotoxicity.

  2005cited by this paper
• Idiosyncratic drug hepatotoxicity

  2005cited by this paper
• Comparative activity of the anti‐convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea‐pig

  2003cited by this paper
• Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat.

  2003influential reference
• A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S,R)-sulfoximine.

  2003cited by this paper
• Drug-induced hepatotoxicity.

  2003cited by this paper
• Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites.

  2002influential reference
• In Vitro, Pharmacokinetic, and Pharmacodynamic Interactions of Ketoconazole and Midazolam in the Rat

  2002cited by this paper
• Analysis of strain difference in sensitivity to cadmium-induced hepatotoxicity in Fischer 344 and Sprague-Dawley rats.

  2002cited by this paper
• Differential selectivity in carbamazepine-induced inactivation of cytochrome P450 enzymes in rat and human liver

  2001cited by this paper
• Alteration of drug biotransformation and elimination during infection and inflammation.

  2001cited by this paper
• Characterization of cytochrome P450 enzymes involved in drug oxidations in mouse intestinal microsomes

  2000cited by this paper
• Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate.

  1999influential reference
• Carbamazepine induces multiple cytochrome P450 subfamilies in rats.

  1999cited by this paper
• Comparison of the effects of some CYP3A and other enzyme inducers on replicative DNA synthesis and cytochrome P450 isoforms in rat liver.

  1998cited by this paper
• Role of glutathione conjugation in protection of weanling rat liver against acetaminophen-induced hepatotoxicity.

  1997cited by this paper
• Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicity.

  1997cited by this paper
• Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes.

  1997influential reference
• Bioactivation of carbamazepine in the rat in vivo. Evidence for the formation of reactive arene oxide(s).

  1996cited by this paper
• Protein-reactive metabolites of carbamazepine in mouse liver microsomes.

  1996cited by this paper
• The management of epilepsy in the 1990s. Acquisitions, uncertainties and priorities for future research.

  1995cited by this paper
• Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation.

  1994cited by this paper
• P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer.

  1994cited by this paper
• Zonation of cytochrome P450 isozyme expression and induction in rat liver.

  1992cited by this paper
• An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro.

  1992cited by this paper
• Detection of an autoantibody directed against human liver microsomal protein in a patient with carbamazepine hypersensitivity.

  1992cited by this paper
• The acute hepatotoxicity of the isomers of dichlorobenzene in Fischer-344 and Sprague-Dawley rats: isomer-specific and strain-specific differential toxicity.

  1991cited by this paper
• Pretreatment with drinking water solutions containing trichloroethylene or chloroform enhances the hepatotoxicity of carbon tetrachloride in Fischer 344 rats.

  1991cited by this paper
• Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone.

  1982cited by this paper
• Metabolism of carbamazepine.

  1982influential reference
• Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

  1979cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues.

  1969cited by this paper
• Conjugations with glutathione. Distribution of glutathione S-aryl transferase in wild birds.

  1968cited by this paper

• Contribution of Japanese scientists to drug metabolism and disposition.

  2025cites this paper
• A microfluidic liver-like model for antiepileptic drugs hepatotoxicity evaluation

  2025cites this paper
• Matricin Modulates Carbamazepine-Induced Acute Tubulointerstitial Nephritis in Rat Models of Alzheimer’s Disease via MEK-JAK2-STAT3 Signaling

  2024cites this paper
• Preclinical liver toxicity models: advantages, limitations and recommendations.

  2024cites this paper
• Pharmacokinetics and metabolism of ketoconazole after single ocular instillation in Sprague-Dawley rats

  2024cites this paper
• Metabolic Activation and Cytotoxicity of Gramine Mediated by CYP3A in Rats.

  2024cites this paper
• Highly Sensitive Determination of Carbamazepine and Oxcarbazepine and Identification of Their Degradation Products in Material Evidences and Human Cadaveric Liver by Gas Chromatography–Mass Spectrometry

  2023cites this paper
• Высокочувствительное определение карбамазепина, окскарбазепина, идентификация продуктов их деградации в вещественных доказательствах и в трупном материале печени человека методом ГХ-МС

  2023cites this paper
• Evaluation of in vitro hepatotoxicity of perampanel in comparison with carbamazepine: old versus new

  2023cites this paper
• Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury

  2022cites this paper
• Inhibition of autophagy with expression of NADPH oxidase subunit p22phox in preneoplastic lesions in a high-fat diet and streptozotocin-related hepatocarcinogenesis rat model.

  2022cites this paper
• Exploration on different animal models used in drug-induced adverse reactions research; current scenario and further prospectives

  2022cites this paper
• Assessment of hepatic prostaglandin E2 level in carbamazepine induced liver injury

  2022cites this paper
• Kupffer cells play a crucial role in monocrotaline-induced liver injury by producing TNF-α.

  2022cites this paper
• Colour Changes during the Carbamazepine Oxidation by Photo-Fenton

  2021cites this paper
• Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction

  2021cites this paper
• Carbamazepine-induced renal toxicity may be associated with oxidative stress and apoptosis in male rat

  2021cites this paper
• Noninvasive monitoring of hepatic glutathione depletion through fluorescence imaging and blood testing

  2021cites this paper
• Effect of CYP3A inducer/inhibitor on pharmacokinetics of five alkaloids in Evodiae Fructus.

  2020cites this paper
• Hypoxia/reoxygenation exacerbates drug-induced cytotoxicity by opening mitochondrial permeability transition pore: Possible application for toxicity screening.

  2020cites this paper
• PXR-mediated idiosyncratic drug-induced liver injury: mechanistic insights and targeting approaches

  2020cites this paper
• [Recent advances in evaluation studies for drug-induced liver injury].

  2020cites this paper
• Models of Idiosyncratic Drug-Induced Liver Injury.

  2020cites this paper
• Graded doses of grape seed methanol extract attenuated hepato-toxicity following chronic carbamazepine treatment in male Wistar rats

  2020cites this paper
• Acute kidney injury model established by systemic glutathione depletion in mice

  2019cites this paper
• UHPLC-MS/MS method for simultaneous determination of carbamazepine and its seven major metabolites in serum of epileptic patients.

  2019cites this paper
• Fundamental Toxicological Sciences

  2019influential citation
• Establishment of a mouse model of troglitazone‐induced liver injury and analysis of its hepatotoxic mechanism

  2019cites this paper
• Inhibition of biliary network reconstruction by benzbromarone delays recovery from pre-existing liver injury.

  2019cites this paper
• Role of cytochrome P450-mediated metabolism and involvement of reactive metabolite formations on antiepileptic drug-induced liver injuries.

  2018cites this paper
• Coadministration of antiepileptic drugs and P-glycoprotein inhibitors of flavonoid-type

  2018cites this paper
• Strain and interindividual differences in lamotrigine‐induced liver injury in mice

  2018cites this paper
• The Modulatory Role of CYP3A4 in Dictamnine-Induced Hepatotoxicity

  2018cites this paper
• CYP3A Activation and Glutathione Depletion Aggravate Emodin-Induced Liver Injury.

  2018cites this paper
• Multifunctional carbamazepine loaded nanostructured lipid carrier (NLC) formulation

  2018cites this paper
• Application of the comparison approach to open TG-GATEs: A useful toxicogenomics tool for detecting modes of action in chemical risk assessment.

  2018cites this paper
• KARBAMAZEPIN-INDUCERAD LEVERTOXICITET - ETT LITTERATURARBETE

  2017influential citation
• In Silico Identification of Bioremediation Potential: Carbamazepine and Other Recalcitrant Personal Care Products.

  2017cites this paper
• Effect of carbamazepine on expression of UDP-glucuronosyltransferase 1A6 and 1A7 in rat brain.

  2017cites this paper
• Association of a reactive intermediate derived from 1′,6‐dihydroxy metabolite with benzbromarone‐induced hepatotoxicity

  2017cites this paper
• Pathogenetic analyses of carbamazepine-induced liver injury in F344 rats focused on immune- and inflammation-related factors.

  2016cites this paper